Skip to main content
Signal8

Glucotrack, Inc. (GCTK)

GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

GlucoTrack, Inc. logo

GlucoTrack, Inc.

OTC:GCTKOTC (suspended from Nasdaq on Oct 30, 2026)Healthcare
-0.21%$0.1900
Mkt Cap$225K
EV-
Float1.09M
O/S1.18M
VOL7K sh
$ Vol$1K
RVOL0.00×
Inst Own3.9%
SI53.8%
Net Cash/Sh-
Dilution
GlucoTrack, Inc. logoOTC:GCTK$0.1900-0.21%
Short interest (FINRA)
53.8%
Oct 30 (18d)

Float 1.09M · Signal8 dilution snapshot · Oct 28, 2026

584.1K
Oct 30 (18d)prev 72.4K▲ 707.2%
1.00
Oct 30 (18d)prev 1.00– 0.0%
Borrow (IBKR)

The cost to borrow GCTK shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
42.9%
Nov 16 (1d)prev 39.9%▲ 3.0 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

234.5K
Oct 30 (18d)prev 421.7K▼ 44.4%
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Fails to deliver24 settlement dates
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 2026584.1K sh
Oct 15, 202672.4K sh
Sep 30, 202661.1K sh
Sep 15, 202648.3K sh
Aug 31, 202612.5K sh
Latest fails to deliver
DateShares failed
Oct 30, 2026234.5K sh
Oct 29, 2026421.7K sh
Oct 28, 2026170.6K sh
Oct 27, 2026316.1K sh
Oct 22, 20262.6K sh

A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 16
Latest sessions
DateReported short
Nov 16, 202642.9%
Nov 13, 202639.9%
Nov 12, 20268.2%
Nov 11, 20263.0%
Nov 10, 202611.3%
90-session median 37.8%mean 39.2%range 3.0–76.9%

130 calendar days requested; 91 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for GCTK: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 584,100 GCTK shares were sold short (53.75% of a 1.09M-share float, 1.00 days to cover).